Sinil Pharmaceutical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was KRW 20,396.46 million compared to KRW 16,507.45 million a year ago. Net income was KRW 2,457.41 million compared to KRW 1,733.66 million a year ago. Basic earnings per share from continuing operations was KRW 212.5 compared to KRW 150 a year ago. Basic earnings per share was KRW 212.5 compared to KRW 150 a year ago.
For the nine months, sales was KRW 545.04 million compared to KRW 593.39 million a year ago. Net income was KRW 8,495.73 million compared to KRW 4,107.9 million a year ago. Basic earnings per share from continuing operations was KRW 734.6154 compared to KRW 354.8077 a year ago. Basic earnings per share was KRW 734.6154 compared to KRW 354.8077 a year ago.